LINC01932

Across TCGA pan-cancer cohorts, LINC01932 RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of LINC01932’s most consistent transcriptional readouts.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where LINC01932 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LINC01932 is over-expressed in tumor, although a few such as READ and PRAD show the opposite, repressed pattern.

HNSC, UCEC, and LUSC are the cancer types where LINC01932 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC01932 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
HNSC	Male	IV	+1.834	<.001	10	view →
UCEC	All	All	+0.245	.006	4	view →
LUSC	All	All	+0.494	.008	2	view →
READ	All	All	−0.075	.025	2	view →
PRAD	All	All	−0.068	.012	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

LINC01932–HNSC

Open the HNSC breakdown →